Showing results (261-270 of 304) with videos related to
Sort By:
Pageof 31
Neurology|April 13, 2005
Microbleeds in hereditary cerebral hemorrhage with amyloidosis-Dutch typeR van den Boom, M Bornebroek, F Behloul, et al.Stroke|August 26, 1998
Microvasculopathy is associated with the number of cerebrovascular lesions in hereditary cerebral hemorrhage with amyloidosis, Dutch typeR Natté, H V Vinters, M L Maat-Schieman, et al.Alzheimer Disease and Associated Disorders|January 1, 1996
Hereditary cerebral hemorrhage with amyloidosis-Dutch type: better correlation of cognitive deterioration with advancing age than with number of focal lesions or white matter hyperintensitiesM Bornebroek, M A Van Buchem, J Haan, et al.Nuclear Medicine Communications|November 1, 1996
Potential for imaging cerebral amyloid deposits using 123I-labelled serum amyloid P component and SPETM Bornebroek, J F Verzijlbergen, J Haan, et al.Cephalalgia : an International Journal of Headache|April 24, 2015
Detoxification in medication-overuse headache, a retrospective controlled follow-up study: Does care by a headache nurse lead to cure?J A Pijpers, M A Louter, M E de Bruin, et al.Neuroradiology|January 1, 1990
Hereditary cerebral hemorrhage with amyloidosis--Dutch type. Tc-99m HM-PAO single photon emission computed tomographyJ Haan, M J van Kroonenburgh, P R Algra, et al.Pharmacotherapy|June 14, 2024
Corticosteroids in critically ill patients: A narrative reviewBradley J Haan, Samantha N Blackmon, Alex M Cobb, et al.American Journal of Medical Genetics|June 19, 1998
Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patientsA Maassen VanDenBrink, M N Vergouwe, R A Ophoff, et al.Brain : a Journal of Neurology|December 28, 1999
Ergotamine in the acute treatment of migraine: a review and European consensusP Tfelt-Hansen, P R Saxena, C Dahlöf, et al.Lancet (London, England)|October 25, 2001
Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trialD J Goldstein, K I Roon, W W Offen, et al.Pageof 31